Small High-Density Lipoprotein (HDL) Subclasses are Increased with Decreased Activity of HDL-Associated Phospholipase A2 in Subjects with Prediabetes

Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men

(2013) J. Wang et al.   JOURNAL OF INTERNAL MEDICINE

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study

(2013) TD Filippatos et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes

(2012) R.I. Coniglio et al.   CLINICAL BIOCHEMISTRY

High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes

(2012) Li Tian et al.   Lipids in Health and Disease

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease

(2012) Anastazia A. Kei et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?

(2012) Aneta Otocka-Kmiecik et al.   PROGRESS IN LIPID RESEARCH

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

(2011) C. Morgantini et al.   DIABETES

Standards of Medical Care in Diabetes--2012

(2011)   DIABETES CARE

Prediabetes: To treat or not to treat?

(2011) Elisavet Moutzouri et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The complexity of HDL

(2010) Gordon A. Francis   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Dysfunctional High-Density Lipoprotein and Atherosclerosis

(2010) Shawn Ragbir et al.   Current Atherosclerosis Reports

High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease

(2010) Christian Besler et al.   CURRENT PHARMACEUTICAL DESIGN

The Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients

(2010) E. S. Nakou et al.   LIPIDS

Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

(2009) Constantinos C. Tellis et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia

(2009) Michael S. Kostapanos et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

(2008) Esther M. M. Ooi et al.   CLINICAL SCIENCE

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

(2008) E. S. Nakou et al.   CURRENT MEDICAL RESEARCH AND OPINION

Economic Costs of Diabetes in the U.S. in 2007

(2008)   DIABETES CARE

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia

(2008) ES Nakou et al.   EXPERT OPINION ON PHARMACOTHERAPY

Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome

(2008) Theodosios D. Filippatos et al.   Journal of Clinical Lipidology

Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile

(2008) G Dell'Omo et al.   JOURNAL OF HUMAN HYPERTENSION

Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome

(2008) K. G. Lagos et al.   LIPIDS

The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome

(2007) T. D. Filippatos et al.   DIABETES OBESITY & METABOLISM

Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women

(2007) T. Tzotzas et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES